![](https://webarchive.library.unt.edu/web/20081012070430im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/web/20081012070430im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/web/20081012070430im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/web/20081012070430im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/web/20081012070430im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/web/20081012070430im_/http://www.nci.nih.gov/images/spacer.gif)
| Compuesto que contiene el radioisótopo itrio Y 90 ligado a la sustancia química biotina. La biotina es una molécula que se une firmemente a la sustancia química estreptavidina. El itrio Y 90 DOTA-biotina localiza las células tumorales en el cuerpo que son el objetivo de un antibiótico ligado a la estreptavidina y las destruye. Está en estudio, junto con la CC49-estreptavidina, para el tratamiento del cáncer. También se llama 90Y-DOTA-biotina. |
![](https://webarchive.library.unt.edu/web/20081012070430im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/web/20081012070430im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/web/20081012070430im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/web/20081012070430im_/http://www.nci.nih.gov/images/spacer.gif) |